{
  "units": [
    {
      "title": "Integrate transcriptome and chromatin accessibility data to construct metacells",
      "text": "we integrated the two modalities by constructing metacells containing both transcriptome and chromatin accessibility information, defining a total of 24 clusters from 35,499 metacells (Fig. 4a and Supplementary Table 3).",
      "rationale": "This is an actionable protocol step for integrating multi-omic data to define cell clusters.",
      "detected_categories": [],
      "split_audit": {
        "char_count": 220,
        "word_count": 31,
        "sentence_count": 2,
        "category_count": 0,
        "flags": [
          "UNIT_NO_EXPERIMENT_CATEGORY"
        ]
      }
    },
    {
      "title": "Infer terminal macrostates and transition probabilities using CellRank",
      "text": "To follow cell trajectories over time, we used CellRank47 to infer the terminal macrostates (myocytic, epicardial, endothelial and endodermal) and the probability of each cell to transition toward these states based on both pseudotime and RNA velocity information (Fig. 4b and Extended Data Fig. 7a).",
      "rationale": "This describes a specific computational protocol for trajectory inference using CellRank.",
      "detected_categories": [],
      "split_audit": {
        "char_count": 300,
        "word_count": 45,
        "sentence_count": 3,
        "category_count": 0,
        "flags": [
          "UNIT_NO_EXPERIMENT_CATEGORY"
        ]
      }
    },
    {
      "title": "Generate hiPSC reporter line with FRT-flanked STOP-mKate2-HA",
      "text": "To functionally validate the fate potential of different progenitor populations in epicardioids, we generated an hiPSC reporter line in which a flippase (FLP) recognition target (FRT)-flanked neomycin cassette blocking transcription of a pCAG-driven fluorescent reporter (mKate2) fused to a hemagglutinin (HA) tag was knocked into the AAVS1 safe harbor locus49 (Supplementary Results and Supplementary Fig. 4a–f).",
      "rationale": "This is a precise genetic engineering protocol step for creating a lineage-tracing reporter line.",
      "detected_categories": [
        {
          "id": "microscopy_imaging",
          "hits": 1,
          "confidence": 0.25,
          "matched_patterns": [
            "fluorescen"
          ]
        }
      ],
      "split_audit": {
        "char_count": 413,
        "word_count": 59,
        "sentence_count": 2,
        "category_count": 1,
        "flags": []
      }
    },
    {
      "title": "Transduce epicardioids with FLP-encoding lentivirus under CDH1 promoter",
      "text": "For JCF lineage tracing, epicardioids from this reporter line were transduced with a lentiviral vector encoding FLP under the control of the CDH1 promoter at day 15 (Fig. 5a and Extended Data Fig. 9a).",
      "rationale": "This specifies a timed, promoter-driven viral transduction protocol for lineage labeling.",
      "detected_categories": [
        {
          "id": "molecular_cloning",
          "hits": 1,
          "confidence": 0.143,
          "matched_patterns": [
            "vector"
          ]
        }
      ],
      "split_audit": {
        "char_count": 201,
        "word_count": 34,
        "sentence_count": 3,
        "category_count": 1,
        "flags": []
      }
    },
    {
      "title": "Apply 4-hydroxytamoxifen (4-OHT) to induce FLP activity during JCF stage",
      "text": "4-hydroxytamoxifen (4-OHT) was applied at the beginning of the JCF stage (days 7–8; Fig. 4e and Extended Data Fig. 8a).",
      "rationale": "This is a timed pharmacological induction step critical for lineage tracing experiments.",
      "detected_categories": [],
      "split_audit": {
        "char_count": 119,
        "word_count": 23,
        "sentence_count": 4,
        "category_count": 0,
        "flags": [
          "UNIT_TOO_SHORT_CHARS",
          "UNIT_NO_EXPERIMENT_CATEGORY"
        ]
      }
    },
    {
      "title": "Apply 4-OHT during FHF stage (days 4–5) as alternative induction",
      "text": "Alternatively, we applied 4-OHT at the corresponding stage (days 4–5; Extended Data Fig. 8c).",
      "rationale": "This describes an alternative timing protocol for inducing FLP activity during FHF stage.",
      "detected_categories": [],
      "split_audit": {
        "char_count": 93,
        "word_count": 16,
        "sentence_count": 3,
        "category_count": 0,
        "flags": [
          "UNIT_TOO_SHORT_CHARS",
          "UNIT_TOO_SHORT_WORDS",
          "UNIT_NO_EXPERIMENT_CATEGORY"
        ]
      }
    },
    {
      "title": "Perform immunofluorescence analysis for HA tag and lineage markers at day 24",
      "text": "On day 24, immunofluorescence analysis revealed HA-tag+ SMCs and fibroblasts but also CMs (Fig. 5b, Supplementary Video 3 and Extended Data Fig. 9c), supporting the fate potentiality previously inferred from gene expression (Fig. 1h,i).",
      "rationale": "This is a clear protocol step for validating lineage tracing outcomes via immunostaining.",
      "detected_categories": [
        {
          "id": "dna_rna_extraction",
          "hits": 1,
          "confidence": 0.143,
          "matched_patterns": [
            "lysis"
          ]
        },
        {
          "id": "microscopy_imaging",
          "hits": 1,
          "confidence": 0.25,
          "matched_patterns": [
            "fluorescen"
          ]
        }
      ],
      "split_audit": {
        "char_count": 236,
        "word_count": 36,
        "sentence_count": 4,
        "category_count": 2,
        "flags": []
      }
    },
    {
      "title": "Subcluster epicardial lineage at day 15 and analyze trajectories with CellRank",
      "text": "We then exploited our metacell dataset to investigate the timing of epicardial fate decisions. For this, we performed subclustering of the epicardial lineage at day 15 (differentially expressed genes (DEGs) listed in Supplementary Table 6) and analyzed cell trajectories using CellRank.",
      "rationale": "This outlines a specific analytical protocol for subclustering and trajectory analysis of epicardial cells.",
      "detected_categories": [],
      "split_audit": {
        "char_count": 286,
        "word_count": 41,
        "sentence_count": 2,
        "category_count": 0,
        "flags": [
          "UNIT_NO_EXPERIMENT_CATEGORY"
        ]
      }
    },
    {
      "title": "Co-stain HA tag and ISL1 to confirm JCF labeling after 48 h",
      "text": "In the absence of a reliable antibody to MAB21L2, we performed co-staining of the HA tag and ISL1 after 48 h to confirm successful labeling of ISL1+ JCF cells located at the outer layer (Extended Data Fig. 8b).",
      "rationale": "This is a validation protocol step using immunofluorescence co-staining to confirm target cell labeling.",
      "detected_categories": [],
      "split_audit": {
        "char_count": 210,
        "word_count": 39,
        "sentence_count": 2,
        "category_count": 0,
        "flags": [
          "UNIT_NO_EXPERIMENT_CATEGORY"
        ]
      }
    },
    {
      "title": "Analyze chromatin accessibility patterns along epicardial differentiation trajectories",
      "text": "Assessing chromatin accessibility patterns along epicardial differentiation pathways revealed that chromatin states associated with lineage commitment were dynamically remodeled during EMT.",
      "rationale": "This describes a protocol step for integrating ATAC-seq or similar data to assess epigenetic dynamics during differentiation.",
      "detected_categories": [],
      "split_audit": {
        "char_count": 189,
        "word_count": 21,
        "sentence_count": 1,
        "category_count": 0,
        "flags": [
          "UNIT_NO_EXPERIMENT_CATEGORY"
        ]
      }
    }
  ],
  "created_at": "2026-02-16T13:21:18.827494+00:00"
}